TheraEDGE
An integrated platform enabling Theranostic applications at the Point of Primary Care
| Coordinatore | BIOKIT S.A.
Organization address
address: CAN MALE contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 11˙783˙434 € |
| EC contributo | 8˙000˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2007-1 |
| Funding Scheme | CP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-03-01 - 2012-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 | BIOKIT S.A. | ES | coordinator | 0.00 |
| 2 |
CLINICAL RESEARCH ASSOCIATES & CONSULTANTS S.R.O.
Organization address
address: CUKROVA 14 contact info |
SK (BRATISLAVA) | participant | 0.00 |
| 3 |
HOSPITAL CLINIC I PROVINCIAL DE BARCELONA
Organization address
address: CALLE VILLARROEL contact info |
ES (BARCELONA) | participant | 0.00 |
| 4 |
INSTITUT FUER MIKROTECHNIK MAINZ GMBH
Organization address
address: Carl-Zeiss-Str. contact info |
DE (Mainz) | participant | 0.00 |
| 5 |
LEWIS TREVOR STANLEY MEDICAL DEVICE CONSULTANCY
Organization address
address: ASHLEY HEATH contact info |
UK (Shropshire) | participant | 0.00 |
| 6 |
LINKOPINGS UNIVERSITET
Organization address
address: CAMPUS VALLA contact info |
SE (LINKOPING) | participant | 0.00 |
| 7 | NTE-SENER, S.A. | ES | participant | 0.00 |
| 8 |
RIDGEBACK S.A.S. DI PAOLO BARATTINI & C.
Organization address
address: VIA SAN FRANCESCO DA PAOLA 6 contact info |
IT (TORINO) | participant | 0.00 |
| 9 |
Systelab Technologies S.A.
Organization address
address: CAN MALE S/N contact info |
ES (LLICA D'AMUNT) | participant | 0.00 |
| 10 |
TECHNISCHE UNIVERSITAET DRESDEN
Organization address
address: HELMHOLTZSTRASSE contact info |
DE (DRESDEN) | participant | 0.00 |
| 11 |
TEKEVER - TECNOLOGIAS DE INFORMACAO, S.A.
Organization address
address: AV. REPUBLICA contact info |
PT (LISBOA) | participant | 0.00 |
| 12 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Organization address
address: The Old Schools, Trinity Lane contact info |
UK (CAMBRIDGE) | participant | 0.00 |
| 13 |
UNIVERSITAET BIELEFELD
Organization address
address: UNIVERSITAETSSTRASSE contact info |
DE (BIELEFELD) | participant | 0.00 |
| 14 |
UNIVERSITAT DE BARCELONA
Organization address
address: GRAN VIA DE LES CORTS CATALANES contact info |
ES (BARCELONA) | participant | 0.00 |
| 15 |
UNIVERSITEIT ANTWERPEN
Organization address
address: PRINSSTRAAT contact info |
BE (ANTWERPEN) | participant | 0.00 |
| 16 |
UNIVERSITEIT TWENTE
Organization address
address: DRIENERLOLAAN contact info |
NL (ENSCHEDE) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
TheraEDGE is an industry-driven effort to accelerate the adoption of theranostics applications in Primary Care by pushing Point of Care Test (POCT) technology far beyond its current state-of-the-art and by delivering clinical, analytical and operational breakthroughs.nTheraEDGE is built around the high-incidence clinical case of early-diagnosing lower respiratory tract infections in Primary Care. Simultaneous testing for different pathogens and their antibiotic resistance will have a huge European impact:n•better clinical outcomes and standards of care through more effective and timely diagnosis and treatmentn•improved health economics through optimization of antibiotics prescription, infection control practices and reduction of clinical visits or hospital staysn•substantial business for the In Vitro Diagnostics industry through the standardisation and commercialization of innovative POCT products and systemsnTheraEDGE consists of three multidisciplinary platforms:n•a core Lab-On-a-Chip supporting multi-marker assays and using Single Molecule Detection (SMD) as an alternative to PCR-based molecular diagnostics. SMD removes the need for amplification and has the potential to become a key enabler for Nucleic Acid Testing at the Point of Care by providing less complex, faster, more sensitive and more specific assaysn•an architecture that provides Plug and Play semantic interoperability and creates opportunities for the standardisation of POCT instruments and information systems, offering radical usability, robustness and vendor interoperability improvements. Practitioners will be able to run out-of-the-box multiple compliant devices from one single PDA-based operator interfacen•a set of applications built on a convergent ITC platform that supports General Practitioners in their patient management and clinical decision-making, and provides therapeutic services for patient education and compliance monitoring in order to fight antibiotic misuse and abuse.